Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Gilead Sciences
Gilead Sciences
Why Gilead Sciences Could Gain 30%
Barron's
Fri, 09/19/14 - 02:18 pm
Gilead Sciences
SOF/LDV
hepatitis C
Gilead Sciences: Failed Trial Always a ‘Long Shot’
Barron's
Thu, 09/18/14 - 12:03 pm
Gilead Sciences
clinical trials
pancreatic cancer
simtuzumab
Dropout rate on $1,000-a-day pill jumps during transition to ‘real world’
Marketwatch
Wed, 09/17/14 - 04:32 pm
Gilead Sciences
Sovaldi
drug pricing
hepatitis C
Gilead's oncology contender comes up short in pancreatic cancer
Fierce Biotech
Wed, 09/17/14 - 09:54 am
Gilead Sciences
simtuzumab
pancreatic cancer
Gilead Deal to Sell Sovaldi in Poor Countries Meets Criticism
WSJ Pharmalot
Mon, 09/15/14 - 07:21 pm
Gilead Sciences
drug pricing
hepatitis C
Sovaldi
U.S. Hepatitis Problem to Continue Driving These 4 Top Stocks
24/7 Wall St
Mon, 09/15/14 - 11:36 am
hepatitis C
Gilead Sciences
AbbVie
Achillion
Merck
Sovaldi
Idenix
Gilead signs pact with 7 firms for cheap copies of hepatitis C drug
Yahoo/Reuters
Mon, 09/15/14 - 08:49 am
Gilead Sciences
Sovaldi
generics
hepatitis C
Cipla
Ranbaxy
Cadila
Mylan Labs
Strides Arcolab
Hetero Drugs
Sequent Scientific
Gilead Sciences: Sovaldi Sales Slip But Less Than Feared
Barron's
Fri, 09/12/14 - 06:58 pm
Gilead Sciences
Sovaldi
hepatitis C
ViiV’s Triumeq to end Gilead’s monopoly in HIV
Pharmaphorum
Wed, 09/10/14 - 11:33 am
ViiV Healthcare
Gilead Sciences
HIV
Triumeq
GSK and Gilead’s combination therapy: positive results in PAH
Pharmaphorum
Tue, 09/9/14 - 10:36 am
GSK
Gilead Sciences
PAH
pulmonary arterial hypertension
Letairis
Adcirca
Can anything slow Gilead down? Analysts say no
CNBC
Mon, 09/8/14 - 08:16 pm
Gilead Sciences
Sovaldi
hepatitis C
Why Gilead Is Falling On Drugs For Developing Nations
Investor's.com
Sat, 09/6/14 - 09:17 am
Gilead Sciences
Cheaper Version Of Gilead's Sovaldi Might Be On The Cards
Bidness Etc.
Fri, 09/5/14 - 08:05 am
Gilead Sciences
Sovaldi
hepatitis C
Gilead Close to Sending $84,000 Drug to Poor Countries
Bloomberg
Thu, 09/4/14 - 06:30 pm
Gilead Sciences
Sovaldi
hepatitis C
Has Gilead Sciences, Inc.'s Star Drug Already Peaked?
Motley Fool
Fri, 08/29/14 - 08:10 am
Gilead Sciences
Sovaldi
hepatitis C
Bristol-Myers gets the approval Gilead didn't want: Daklinza + Sovaldi for hep C
Fierce Pharma Marketing
Wed, 08/27/14 - 10:19 am
Bristol-Myers Squibb
Gilead Sciences
hepatitis C
Daklinza
Sovaldi
Gilead, Jazz Among 4 Top Big Cap Medicals To Watch
Investors.com
Wed, 08/27/14 - 09:56 am
Jazz Pharmaceuticals
Gilead Sciences
Illumina
Salix
Why Gilead Sciences (GILD) Could Beat Earnings Estimates Again
Yahoo/Zacks.com
Fri, 08/22/14 - 12:06 pm
Gilead Sciences
earnings
Gilead (GILD) Hits 52-Week High Thanks to Sovaldi
Yahoo/Zacks.com
Thu, 08/21/14 - 09:43 am
Gilead Sciences
Sovaldi
hepatitis C
UK Says Sovaldi Is Worth It. We Should Listen.
Forbes
Mon, 08/18/14 - 09:20 am
UK
Sovaldi
hepatitis C
Gilead Sciences
Pages
« first
‹ previous
…
70
71
72
73
74
75
76
77
78
…
next ›
last »